Elizabeth Plimack, MD, MS, is a board-certified medical oncology physician, Professor of Medical Oncology, Chief of the Division of Genitourinary Medical Oncology and Director of Genitourinary Clinical Research at Fox Chase Cancer Center in Philadelphia, Pennsylvania.
Her clinical research focus includes kidney, bladder, prostate and testicular cancers, with research efforts focused on the development of new therapies for bladder and kidney cancer.
Dr Plimack serves in multiple leadership roles including serving on the Board of Directors at the American Society of Clinical Oncology (ASCO) and the Society of Urologic Oncology (SUO) Clinical Trials Consortium and on the Scientific Advisory Boards at Bladder Cancer Advocacy Network and The Johns Hopkins Greenberg Bladder Cancer Institute. She is a member of Temple Health LEAD 365’s Physician Leadership Academy, the Bladder Cancer Task Force at the National Cancer Institute (NCI), the Management Committee at Bladder Cancer Research Network, the Kidney Cancer and Bladder/Penile Cancer Guidelines Panels and the 2021 Young Investigator Award Committee at the National Comprehensive Cancer Network.
Dr Plimack has been the recipient of numerous awards for her work. She serves on the Editorial Boards of Cancer and Journal of Clinical Oncology and has authored or coauthored at least 163 peer-reviewed journal articles. Dr Plimack is a member of ASCO, SUO and the American Association of Cancer Research.